Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Icogen's Chemokine Research Receives $1M SBIR Award

Feb. 6, 2003

By Aaron Lorenzo

TransTech Translates Progress Into $24.5M Secured Investment

Feb. 5, 2003

By Aaron Lorenzo

MaxCyte, Northern Therapeutics Enter Gene Therapy Delivery Deal

Feb. 5, 2003

By Aaron Lorenzo

MaxCyte, Northern Therapeutics Enter Gene Therapy Delivery Deal

Feb. 5, 2003

By Aaron Lorenzo

TransTech Translates Progress Into $24.5M Secured Investment

Feb. 5, 2003

By Aaron Lorenzo

Abgenix, Chugai Collaborate On Human Antibody Therapies

Feb. 4, 2003

By Aaron Lorenzo

Pharmacopeia Enters Two Deals, Receives Milestone From Another

Feb. 4, 2003

By Aaron Lorenzo

Abgenix, Chugai Collaborate On Human Antibody Therapies

Feb. 4, 2003

By Aaron Lorenzo

Pharmacopeia Enters Two Deals, Receives Milestone From Another

Feb. 4, 2003

By Aaron Lorenzo

Texas Biotechnology Regaining Rights To PAH Drug From ICOS

Feb. 3, 2003

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...